Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3; the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; older Revision: v3.4.1 and the government funding notice have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:52:22.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Site-wide maintenance notices were added regarding a lapse in government funding and NIH Clinical Center status, and the page revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:32:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary display is now shown; metadata lines updated to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' replacing the previous lowercase variants and earlier revision.
    Difference
    0.2%
    Check dated 2026-01-28T04:33:20.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no study content or data were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:01.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Georgia as a location, and updated the page revision to v3.3.3. Removed the separate Georgia Locations header and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T13:37:56.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.